Bioscience news and upcoming events
News
Lonza Expands its TheraPEAK® Product Portfolio with the Addition of AmpliCell® Cytokine Range and TheraPEAK® 293-GT® Medium
With the launch of TheraPEAK® AmpliCell® Cytokines and TheraPEAK® 293-GT® Medium Lonza expands its GMP solutions for cell and gene therapy.
Introducing next-generation 4D-Nucleofector® LV Unit PRO for improved electroporation in GMP manufacturing
Designed to deliver clinically relevant cargos, this unit builds on Lonza’s well-established non-viral large-scale transfection platform, serving as a scalable and reproducible platform for a seamless translation from research to GMP manufacturing.
Renowned Champalimaud Foundation selects MODA-ES® Platform
Through the installation, the institute plans to improve and streamline the cell therapy manufacturing process
Lonza's Rapid PyroCell® Monocyte Activation Test Systems make rabbit-free pyrogen testing faster, easier, and more efficient
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Lonza launches Nebula® Absorbance Reader for streamlined endotoxin and pyrogen testing
The new Lonza Nebula® Absorbance Reader provides QC labs with a fully optimized absorbance reader. It features high-performance optics and monochromator-based wavelength selection to ensure precise and accurate measurements of endotoxin levels, and reduces the risk of false positives or negatives.
Lonza launches TheraPRO® CHO Media System to improve productivity and quality in therapeutic protein manufacture
Lonza just launched a new GS-CHO cell culture media system to optimize production of therapeutic monoclonal antibodies and recombinant proteins: The TheraPRO® CHO Media System.
Lonza launches TheraPEAK® T-VIVO® Cell Culture Medium to accelerate cell therapy development
Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing.
New Lonza webinar – 'Taking the leap into an MES from a CEO’s perspective'
In this free 45-minute webinar, gain exclusive insight into the lessons the CEO of Exela® Pharma Sciences learned while implementing a Manufacturing Execution System (MES), and the lasting impact it will have on the company.
Upcoming events
BioProcess International Asia
22 - 25 October 2025
Westin Miyako
Kyoto, Japan
Booth# 14
Conference
BioProcess International Asia (BPI Asia) is a premier summit spotlighting the future of biologics manufacturing, with a strong emphasis on protein-based therapies.
CAR-TCR Summit
23 - 26 October 2025
Mariott Copley Place
Boston, MA, USA
Booth #44
Conference
Short Description of the Event: The cell therapy field has seen a lot of positive momentum recently. With Leucid Bio announcing the treatment of first patient in the AERIAL trial, CARsgen announcing preliminary clinical data for their allogeneic CAR-T, Sail Biomedicine presenting preclinical in vivo data for their autoimmune CAR-T, and Cabaletta announcing plans for an anticipated 2027 BLA submission, there is so much to be excited about! Don’t sit back and watch. Join the 10th Anniversary of the CAR-TCR Summit to reflect on a decade of progress whilst engaging in solutions-driven discussions that will empower you to tackle cell therapy development challenges to help shape the future of the field.
PDA Pharmaceutical Microbiology Conference
27 - 29 October 2025
Grand Hyatt
Washington, DC, USA
Booth #412
Conference
Gain practical insights into the latest in pharmaceutical microbiology through focused sessions, case studies, and regulatory updates—designed to help you address today’s challenges and prepare for tomorrow’s innovations in contamination control, emerging technologies, regulatory trends, alternative microbiological methods, ATMPs, and much more!
PDA Pyrogens Workshop
29 - 30 October 2025
Grand Hyatt
Washington, DC, USA
Booth #108
Conference
Industry, pharmacopoeia, and regulatory changes to modernize pyrogen and bacterial endotoxins testing (BET) have created a generational dynamic not seen since the dawn of the BET using horseshoe crab-sourced test reagents. The pyrogenicity concept in Europe is compelling changes to pyrogen testing using rabbits, while compendia changes in the United States create the most inclusive path to converting to recombinant endotoxin reagents. The PDA Pyrogens Workshop 2025 navigates all things pyrogen and endotoxin including the evaluation and adoption of modern test methods including a survey of the regulatory and compendia landscape, test options, and practical application of the tests.
EMBO Workshop - CRISPR-Cas: From biology to therapeutic applications
2 - 5 November 2025
Hilton Sorrento Palace Hotel
Sorrento, Italy
Conference
This EMBO workshop will bring together experts in the editing space, who are studying the CRISPR-Cas immune defence system, developing novel and safer editing approaches, and applying them to the clinic.
Pharmig´s 33rd Annual November Conference
19 - 20 November 2025
Nottigham Belfry Hotel
Nottingham, UK
Conference
PharmaLab 2025
24 - 26 November 2025
Crowne Plaza
Duesseldorf/Neuss, Germany
Booth# 37
Conference
The event for all pharmaceutical laboratory sectors will cover various topics and lectures on analytics, bioanalytics and microbiology.